Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

HTTPS

Secure .gov websites use HTTPS
A lock (LockA locked padlock) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

    • Environmental Topics
    • Air
    • Bed Bugs
    • Cancer
    • Chemicals, Toxics, and Pesticide
    • Emergency Response
    • Environmental Information by Location
    • Health
    • Land, Waste, and Cleanup
    • Lead
    • Mold
    • Radon
    • Research
    • Science Topics
    • Water Topics
    • A-Z Topic Index
    • Laws & Regulations
    • By Business Sector
    • By Topic
    • Compliance
    • Enforcement
    • Laws and Executive Orders
    • Regulations
    • Report a Violation
    • Environmental Violations
    • Fraud, Waste or Abuse
    • About EPA
    • Our Mission and What We Do
    • Headquarters Offices
    • Regional Offices
    • Labs and Research Centers
    • Planning, Budget, and Results
    • Organization Chart
    • EPA History

Breadcrumb

  1. Home
  2. Scientific Leadership

Exploration of Perinatal Pharmacokinetic Issues

EPA tasked Versar, Inc., to convene a team of five expert scientists to assist the Agency in exploring how it might improve risk assessment and toxicity testing paradigms currently in use, and ways to improve the evaluation of pharmacokinetic data in immature animals at various stages of development. A task was defined whose purpose was to develop a White Paper that would review the current state of pharmacokinetic knowledge in the animal and human perinatal population, defined as the unborn, infants and young children. Each technical expert addressed one of five different issue areas or aspects of the scope of work. This report was developed with an eye toward:
 
  1. Identifying information that would inform the development of future test guidelines and/or guidance documents related to this topic
  2. Identifying information or approaches that would assist EPA in improving existing noncancer risk assessment methodologies
  • Exploration of Perinatal Pharmacokinetic Issues (pdf) (2.21 MB, May 10, 2001, 630-R-01-0)

Scientific Leadership

  • Risk Assessment Support
  • Human Subjects Research
    • About Human Subjects Research
    • For EPA Grantees Proposing Human Subjects Research
  • Peer Review
  • Public Access
Contact Us about Programs of the Office of the Science Advisor
Contact Us to ask a question, provide feedback, or report a problem.
Last updated on January 28, 2025
  • Assistance
  • Spanish
  • Arabic
  • Chinese (simplified)
  • Chinese (traditional)
  • French
  • Haitian Creole
  • Korean
  • Portuguese
  • Russian
  • Tagalog
  • Vietnamese
United States Environmental Protection Agency

Discover.

  • Accessibility Statement
  • Budget & Performance
  • Contracting
  • EPA www Web Snapshot
  • Grants
  • No FEAR Act Data
  • Plain Writing
  • Privacy
  • Privacy and Security Notice

Connect.

  • Data
  • Inspector General
  • Jobs
  • Newsroom
  • Regulations.gov
  • Subscribe
  • USA.gov
  • White House

Ask.

  • Contact EPA
  • EPA Disclaimers
  • Hotlines
  • FOIA Requests
  • Frequent Questions
  • Site Feedback

Follow.